Efficacy and Safety of LX9211 in Participants With Postherpetic Neuralgia
Clinical trial NCT04662281 · COMPLETED
Trial details
- NCT number
- NCT04662281
- Sponsor
- Lexicon Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-10
- Primary completion
- 2022-11-18
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.